These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3932999)

  • 41. [Treatment of pulmonary tuberculosis patients with primary drug resistant Mycobacterium tuberculosis].
    Protopopova NM; Bessonova GS; Cherednichenko LP
    Probl Tuberk; 1987; (1):27-30. PubMed ID: 3104897
    [No Abstract]   [Full Text] [Related]  

  • 42. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

  • 43. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
    Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
    Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
    [No Abstract]   [Full Text] [Related]  

  • 44. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 45. [Contagion of drug-resistant Mycobacterium tuberculosis: considerations on the time course of so-called primary resistance].
    Lucchesi M
    Arch Monaldi; 1972; 27(4):436-53. PubMed ID: 4217600
    [No Abstract]   [Full Text] [Related]  

  • 46. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 47. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

  • 48. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 49. [Improved methods of isolating altered forms of Mycobacterium tuberculosis in patients with stable destructive changes in lung tissue].
    Golyshevskaia VI; Akhunov ShB; Bibergal' EA
    Probl Tuberk; 1987; (10):61-5. PubMed ID: 3122201
    [No Abstract]   [Full Text] [Related]  

  • 50. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V; Muzikravić T
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract]   [Full Text] [Related]  

  • 51. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 52. [Epidemiological and clinical significance of resistant tuberculosis bacteria].
    Sighart H
    Wien Med Wochenschr; 1968 Oct; 118(43):923-5. PubMed ID: 4973923
    [No Abstract]   [Full Text] [Related]  

  • 53. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 54. [Primary drug resistance in Mycobacterium tuberculosis among patients with pulmonary tuberculosis and its impact on permanent disability in the Volgograd region].
    Borzenko AS; gagarina SG; Samoĭlova IV; Kalushenina AA
    Probl Tuberk Bolezn Legk; 2007; (12):28-30. PubMed ID: 18326212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
    Khomenko AG; Chesak OI; Biazov TA; Chaikina TN
    Probl Tuberk; 1972; 50(10):28-32. PubMed ID: 4633557
    [No Abstract]   [Full Text] [Related]  

  • 56. [The specific features of a pathogen in acutely progressive pulmonary tuberculosis].
    Balasaniants GS; Greĭmer MS
    Probl Tuberk Bolezn Legk; 2003; (9):29-31. PubMed ID: 14598524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 59. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 Jun; 22(6):519-34. PubMed ID: 4973216
    [No Abstract]   [Full Text] [Related]  

  • 60. [Drug resistance of Mycobacterium tuberculosis in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Lastkov OA
    Vrach Delo; 1981 Aug; (8):72-4. PubMed ID: 6791383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.